资讯

Targeted Oncology2 小时
Navigating CAR T-Cell Therapy Decisions in Relapsed B-Cell Lymphoma
During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...
Targeted Oncology5 小时
Adjuvant Nivolumab Shows Sustained Benefit in Esophageal/GEJ Cancer
Bonilla, MD, MSEd, discusses 5-year data from the phase 3 CheckMate 577 trial, presented at the 2025 ASCO Annual Meeting.
Targeted Oncology7 小时
QUILT-88 Study: Promising Survival in Pancreatic Cancer
The QUILT-88 study reveals promising survival rates for advanced pancreatic cancer patients using a multimodal treatment ...
Targeted Oncology9 小时
Daraxonrasib Earns FDA Breakthrough Status in Pancreatic Cancer
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Targeted Oncology4 小时
Lack of Comparative Trials in R/R MM Complicates Treatment Selection
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.
Targeted Oncology9 小时
Dr Klempner: ASCO 2025 GI Cancer Insights and News
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.